Manfred Stapff, MD, PhD

Executive Clinical Research & Science Professional, Real World Data & Real World Evidence Expert, CMO

About

Dr. Manfred Stapff has over 30 years of experience in the pharmaceutical industry, with expertise in clinical research and drug development. He served as the President of LG Chem Life Science, a global biopharmaceutical company, and as the Chief Medical Officer at TriNetX, a healthcare data analytics company. Dr. Stapff has held various leadership positions in the industry, including Executive Director at Forest Laboratories (now Allergan), Senior Director at Merck and Co Inc, and Vice President of Clinical Development at Millennium Pharmaceuticals. He has also served on the boards of several biopharmaceutical companies. In addition to his industry experience, Dr. Stapff is a trained physician with a PhD in Pharmacology from Ludwig-Maximilians-Universitat Munchen. He has published numerous articles in peer-reviewed medical journals and has been a speaker at various industry conferences. Throughout his career, Dr. Stapff has been dedicated to improving patient outcomes through innovative drug development. He has a strong track record of successfully leading clinical programs and bringing new treatments to market.

Publications

Controlling the Covid-19 Pandemic without Killing the Economy: About Data Driven Decision Making with a Data Model Assessing Local Transmission Risk

Journal of Public Health International / Nov 20, 2020

Stapff, M. (2020). Controlling the Covid-19 Pandemic without Killing the Economy: About Data Driven Decision Making with a Data Model Assessing Local Transmission Risk. Journal of Public Health International, 3(2), 22–29. https://doi.org/10.14302/issn.2641-4538.jphi-20-3621

More on Long-Term Effects of Finasteride on Prostate Cancer Mortality

New England Journal of Medicine / May 16, 2019

More on Long-Term Effects of Finasteride on Prostate Cancer Mortality. (2019). New England Journal of Medicine, 380(20). https://doi.org/10.1056/nejmc1902700

First‐line treatment of essential hypertension: A real‐world analysis across four antihypertensive treatment classes

The Journal of Clinical Hypertension / Apr 13, 2019

Stapff, M., & Hilderbrand, S. (2019). First‐line treatment of essential hypertension: A real‐world analysis across four antihypertensive treatment classes. The Journal of Clinical Hypertension, 21(5), 627–634. Portico. https://doi.org/10.1111/jch.13531

Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes

World Journal of Diabetes / Dec 15, 2018

Stapff, M. P. (2018). Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World Journal of Diabetes, 9(12), 252–257. https://doi.org/10.4239/wjd.v9.i12.252

Experience

LG Chem Life Science

President / 2019 — 2022

TriNetX

Chief Medical Officer / 2015 — 2019

Forest Laboratories (now Allergan)

Executive Director / 2009 — 2015

Merck and Co Inc

Senior Director / 1990 — 2008

Ludwig-Maximilians-Universitat Munchen

1986 — 1990

Join Manfred on NotedSource!

Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.